Idiopathic Hypogonadotropic Hypogonadism
Conditions
Brief summary
Effects of gonadotrophin replacement therapy Lipid Profile and Oxidative Stress Parameters of Patients with Idiopathic Hypogonadotropic Hypogonadism
Detailed description
30 male patients diagnosed with IHH and a control group of 20 healthy cases with similar age and BMI were included in the study. The levels of advanced oxidation protein products (AOPP), thiol, malondialdehyde (MDA), nitric oxide (NO) and 8-hydroxydeoxyguanosine (8-OHdG) and the levels of triglyceride (TG), total cholesterol (TC), high density lipoprotein (HDL-K), low density lipoprotein (LDL-K), Apolipoprotein A1 (ApoA1) and Apolipoprotein B100 (ApoB100) were measured before and after gonadotrophin therapy.
Interventions
drug for the treatment of male hypogonadism
Sponsors
Study design
Eligibility
Inclusion criteria
Serum testosterone concentration \< 300ng/dL Absence of a pituitary or hypothalamic mass lesions, Presence of gonadotropin response to GnRH, -
Exclusion criteria
diabetes mellitus, arterial hypertension other hormone deficiencies \-
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| oxidative stress after hCG and HMG treatment | 2010-2012 |
| HDL levels after hCG treatment | 2010-2012 |
| total cholesterole levels after hCG treatment | 2010-2012 |